학술논문
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
Document Type
Article
Author
Alli, Oladapo; Gottesman, Joan; Guevara, Maria; Hikuam, Chris; Hovind, Laura; Karlsson, Mats; McClaren, Jennifer; McIlleron, Helen; Murtaugh, William; Rolls, Barbara; Shahkolahi, Akbar; Stone, Lynnett; Tegha, Gerald; Tenai, Jacob; Upton, Caryn; Wimbish, Chanelle; Dooley, Kelly E ; Rosenkranz, Susan L; Conradie, Francesca; Moran, Laura; Hafner, Richard; von Groote-Bidlingmaier, Florian; Lama, Javier R.; Shenje, Justin; De Los Rios, Jorge; Comins, Kyla; Morganroth, Joel; Diacon, Andreas H; Cramer, Yoninah S; Donahue, Kathleen; Maartens, Gary
Source
In The Lancet Infectious Diseases July 2021 21(7):975-983
Subject
Language
ISSN
1473-3099